CytomX Therapeutics Inc (CTMX)
4.43
-0.07
(-1.56%)
USD |
NASDAQ |
May 03, 16:00
4.69
+0.26
(+5.87%)
Pre-Market: 20:00
CytomX Therapeutics 1 Year Total Returns (Daily): 168.5% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 03, 2024 | 168.5% |
| May 02, 2024 | 172.7% |
| May 01, 2024 | 198.3% |
| April 30, 2024 | 0.00% |
| April 29, 2024 | -1.23% |
| April 26, 2024 | 1.27% |
| April 25, 2024 | -0.62% |
| April 24, 2024 | 0.00% |
| April 23, 2024 | 1.82% |
| April 22, 2024 | 1.21% |
| April 19, 2024 | -1.76% |
| April 18, 2024 | 4.85% |
| April 17, 2024 | 2.92% |
| April 16, 2024 | 12.05% |
| April 15, 2024 | 18.67% |
| April 12, 2024 | 31.90% |
| April 11, 2024 | 27.98% |
| April 10, 2024 | 31.25% |
| April 09, 2024 | 30.13% |
| April 08, 2024 | 32.05% |
| April 05, 2024 | 38.26% |
| April 04, 2024 | 38.26% |
| April 03, 2024 | 39.61% |
| April 02, 2024 | 41.72% |
| April 01, 2024 | 42.38% |
| Date | Value |
|---|---|
| March 28, 2024 | 43.42% |
| March 27, 2024 | 22.35% |
| March 26, 2024 | 24.12% |
| March 25, 2024 | 25.88% |
| March 22, 2024 | 21.26% |
| March 21, 2024 | 24.44% |
| March 20, 2024 | 23.37% |
| March 19, 2024 | 17.20% |
| March 18, 2024 | 8.60% |
| March 15, 2024 | 1.97% |
| March 14, 2024 | -2.37% |
| March 13, 2024 | 7.69% |
| March 12, 2024 | 15.59% |
| March 11, 2024 | 34.95% |
| March 08, 2024 | 19.05% |
| March 07, 2024 | 17.97% |
| March 06, 2024 | 29.81% |
| March 05, 2024 | 27.10% |
| March 04, 2024 | 28.04% |
| March 01, 2024 | 22.12% |
| February 29, 2024 | 13.95% |
| February 28, 2024 | 18.14% |
| February 27, 2024 | 4.65% |
| February 26, 2024 | -22.54% |
| February 23, 2024 | -32.74% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-83.63%
Minimum
Nov 16 2022
198.3%
Maximum
May 01 2024
-29.85%
Average
-29.78%
Median
Aug 23 2021
1 Year Total Returns (Daily) Benchmarks
| Ocular Therapeutix Inc | -0.32% |
| Bristol-Myers Squibb Co | -31.15% |
| ACADIA Pharmaceuticals Inc | -19.58% |
| Cytokinetics Inc | 65.91% |
| Calidi Biotherapeutics Inc | -98.08% |